Egresado de la Universidad Nacional de Trujillo, Médico Cirujano 1974.
Especialidad en Hospital E. Rebagliati y dermatología Universidad Mayor de San Marcos 1975-1978.
Certificado en el Colegio Medico del Peru, número 9241, 1974 y Registro Nacional de Especialidad 14889.
CERTIFICADOS
Certificado por Educational Commision Foreign Medical graduates 1974
Cirugía dermatológica CILAD 1988.
Dermatología cosmética Mexico Certificado número 017 en la Republica Mexicana para la
Aplicación Cosmética de Botox (arrugas).
Certificado para la aplicación de substancias de relleno (arrugas en cara)Brasil Sociedades y Academias Desde 1986.
Miembro de la Sociedad Peruana De Dermatologia Desde 1987.
Miembro del Colegio Ibero Latino Americano de Dermatologia Desde 1987.
Miembro de la Sociedad Bolivariana de Dermatología. Desde 1995 Miembro del Circulo
Dermatologico del Peru (CIDERM) Desde 1995.
Miembro de la American Academy of Dermatology Desde 1997.
Miembro de la Sociedad de Cirugía Dermatológica Desde 1997.
Miembro de la Sociedad de Criocirugía.
ASISTENCIA A CONGRESOS 1983 A 2009
Diversos países del mundo 58 congresos.
15 Ponencias en congresos internacionales.
30 Ponencias en congresos nacionales.
Multiples publicaciones científicas en revistas médicas nacionales e internacionales.
Hospital Regional Docente, Trujillo-Perú
1994-1995
Servicio Social
Centro Materno Infantil Vista Alegre, Trujillo-Peru
1996-1997
Rotación en Cirugía Dermatológica
Instituto Dermatológico “Dr. José Barba Rubio” Guadalajara-Mexico
1998
Post-doctoral Research Fellowship en Dermatologia
University of Texas Southwestern Medical Center at Dallas,USA
1999-2003
Clinical Research Coordinator
Departamento de Dermatología
University of Texas Southwestern Medical Center at Dallas, USA
2003-2008
El Dr. Ian Guevara ha participado en diversos estudios clinicos en Dallas-Texas y ha publicado en diversas revistas dermatologicas en Español e Ingles . Aqui algunos de sus estudios y publicaciones:
PHARMACEUTICAL STUDIES :
Investigator:
An assessment of the atrophogenic potential of triple combination cream using histology measures in the treatment of moderate to severe Melasma, Galderma, 2006-2007
Investigator:
Epidemiological study of Melasma in the Dallas/Ft. Worth area, Galderma, 2004
Investigator:
Melasma-Topical depigmenting agent, ICN Pharmaceuticals, 2002
Investigator:
An open label safety and efficacy study of Solage to assess pigmentary changes, Galderma, 2002
Investigator:
Melasma-Topical depigmenting agent, ICN Pharmaceuticals, 2000
Investigator:
Melasma-Topical depigmenting agent and chemical peeling,ICN Pharmaceuticals,1999
Investigator:
Treatment of HIV/AIDS-related skin disease, NIH RO1-AR43996, 1999
PEER REVIEWED PUBLICATIONS :
Guevara IL, Pandya AG. Melasma treated with hydroquinone, tretinoin, and a fluorinated steroid. Int J Dermatol 2001, 40:210-215.
Hurley ME, Guevara IL , Gonzales RM, Pandya AG. Assessment of the safety and efficacy of glycolic acid peels plus hydroquinone against hydroquinone alone in depigmenting epidermal melasma. Arch Dermatol, 2002, 138:1578-1582.
Guevara IL and Pandya AG. Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants and sunscreen in the treatment of melasma. Int J Dermatol 2003;42:966-972.
Werlinger KD, Guevara IL , Gonzalez CM, Rincon ET, Caetano R, Haley RW, Pandya AG . Prevalence of Self-diagnosed Melasma Among Premenopausal Latino Women in Dallas and Fort Worth, Tex. Arch Dermatol , 2007; 143 (3):424-425.
CASE REPORTS :
Guevara IL , Pandya AG. Vitiligo:Despigmentación con monobenzyl eter de hidroquinona, Folia Dermatológica Peruana 1999;10:39-40.
Guevara IL, Sánchez VPG, Pandya AG . Dos casos de hiperpigmentación inducida por minociclina. Revisión de la literatura. Dermatología 2004; 2:242-244.
REVIEWS & BOOK CHAPTERS :
Pandya AG, Guevara IL . Disorders of hyperpigmentation. Dermatologic Clinics. 2000;18(1):91-98.
ABSTRACTS AND LETTERS TO THE EDITOR:
Hurley ME, Guevara IL , Gonzales RM, Pandya AG. Response to William P. Coleman III, MD and Harold J. Brody, MD regarding their comments on the article, “Efficacy of glycolic acid peels in the treatment of melasma” ( Arch Dermatol 2002;138:1578-1582). Arch Dermatol 2003;139:811-812.
Werlinger K, Guevara IL , Gonzales C, Rincon E, Haley R, Caetano R, Pandya AG .
Prevalence of Melasma among premenopausal Latino women in Dallas and Fort Worth, TX, USA. J Invest Dermatol . Abstract #298; 2006; 126:4; 50.
DERMATOLOGY NEWSPAPER ARTICLES:
Guevara IL . Hydroquinone combo effective for melasma. Article by Sherry Boschert. Skin and Allergy news . 2003; September.
POSTER PRESENTATIONS :
Werlinger K, Guevara IL , Gonzales C, Rincon E, Haley R, Caetano R, Pandya AG .
Prevalence of Melasma among premenopausal Latino women in Dallas and Fort Worth, TX, USA. Society for Investigative Dermatology 67 th Annual Meeting, Philadelphia, Pennsylvania, May 3-6, 2006.
Guevara IL , Werlinger KD, Pandya AG. Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, hyaluronic acid, antioxidants, and sunscreen. American Academy of Dermatology, Summer Meeting, July 2003, Chicago, Illinois.
Guevara IL , Pandya AG. An assessment of the safety and efficacy of a cream containing 4% hydroquinone, 10% buffered glycolic acid, vitamins C and E, and sunscreen in depigmenting epidermal melasma of the face. American Academy of Dermatology, 60 th Annual Meeting, February 2002, New Orleans, Louisiana.
Hurley ME, Guevara IL, Gonzales RM, Pandya AG. Assesssment of the safety and efficacy of glycolic acid peels plus hydroquinone against hydroquinone alone in depigmenting epidermal melasma. American Academy of Dermatology 58 th Annual Meeting, March,2000, San Francisco, California.
Guevara IL, Pandya AG. Treatment of Melasma with tretinoin, triamcinolone acetonide and hydroquinone with photographic documentation. 5 th Reunión Internacional de Terapeútica Dermatológica , July, 1999, Monterrey, Mexico.